Effectiveness of norethisterone enantate in the treatment of the climacteic syndrome.
The Authors have studied the effects of Norethisterone enantate given i.m. every one or two months to 75 patients complaining of climacteric syndrome either spontaneous or induced surgically. An overall evaluation of the effectiveness of the treatment allowed the conclusion that with both timing of administration it is possible to obtain in the majority of patients (80%) a very good control of the climacteric symptoms with negligible side effects. A more careful clinical and laboratory evaluation has shown a fast regression of the symptoms already after one month of drug administration. Therefore norethisterone enantate may be considered an effective therapeutic alternative to estrogens and androgens in the management of the climacteric syndrome.
D000328:Adult; D002979:Climacteric / Q000187:drug effects*; D005260:Female; D006062:Gonadotropins / Q000097:blood; D006801:Humans; D008875:Middle Aged; D009640:Norethindrone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood
D006062:Gonadotropins; D011388:Prolactin; C024319:norethindrone enanthate; D009640:Norethindrone